Market Cap 88.87M
Revenue (ttm) 3.79M
Net Income (ttm) -6.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -170.71%
Debt to Equity Ratio 0.02
Volume 7,395
Avg Vol 2,654
Day's Range N/A - N/A
Shares Out 41.82M
Stochastic %K 94%
Beta 0.79
Analysts Strong Buy
Price Target N/A

Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
Address:
4-6 Southampton Crescent, Abbotsford, Australia
Latest News on SPHRY
No data available.